Key facts
- This page summarizes Merilee Raines's Form 4 filing for TransMedics Group, Inc. (TMDX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 May 2024, 17:30.
Merilee Raines - 23 May 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)
- Reporting relationship
- Director
- Issuer ticker
- TMDX
- Reported as of
- 23 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 May 2024, 17:30:17 UTC
- Prior SEC filing
- 31 Jul 2023
- Next SEC filing
- 26 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Stephen Gordon, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Merilee Raines filed Form 4 for TransMedics Group, Inc. (TMDX) on 28 May 2024.
Change
- Previous filing in this sequence was filed on 31 Jul 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TMDX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +732
- Change %
- +61%
- Price
- $0.000000
- Shares after
- 1,925
- Date
- 23 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TMDX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +1,154
- Change %
- Price
- $0.000000
- Shares after
- 1,154
- Date
- 23 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,154
- Exercise price
- $137.53
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Consists of 732 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F2
The option vests in full on the earlier of May 23, 2025 or the date of the 2025 annual meeting of the stockholders of the Issuer, subject to continued service.